Identification of the primate-specific gene BTN3A2 as an additional schizophrenia risk gene in the MHC loci

May 29, 2019EBioMedicine

The primate-specific gene BTN3A2 as a new schizophrenia risk gene in the immune-related MHC region

AI simplified

Abstract

BTN3A2 has been identified as a potential risk gene for schizophrenia.

  • BTN3A2 expression is highest in the human brain after birth.
  • Overexpression of BTN3A2 in rat hippocampal slices specifically suppresses excitatory synaptic activity onto CA1 pyramidal neurons.
  • The interaction between BTN3A2 and presynaptic adhesion molecules called neurexins may play a role in this suppression.
  • These findings suggest a possible mechanism by which increased BTN3A2 expression could contribute to schizophrenia risk.

AI simplified

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • πŸ“š7 fresh studies
  • πŸ“plain-language summaries
  • βœ…direct links to original studies
  • πŸ…top journal indicators
  • πŸ“…weekly delivery
  • πŸ§˜β€β™‚οΈalways free